nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Darunavir—Weight decreased—Prednisone—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Darunavir—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Darunavir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Darunavir—Cough—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Darunavir—Dizziness—Captopril—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Darunavir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Darunavir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Darunavir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Darunavir—Urticaria—Leflunomide—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Darunavir—Abdominal pain—Leflunomide—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Darunavir—Body temperature increased—Leflunomide—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Darunavir—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Darunavir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Darunavir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Darunavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Darunavir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Darunavir—Myocardial infarction—Prednisone—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Darunavir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Darunavir—Breast disorder—Methotrexate—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Darunavir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Darunavir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Darunavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Darunavir—Insomnia—Lisinopril—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Darunavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Darunavir—Paraesthesia—Lisinopril—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Darunavir—Vomiting—Captopril—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Darunavir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Darunavir—Dyspnoea—Lisinopril—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Darunavir—Rash—Captopril—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Darunavir—Dermatitis—Captopril—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Darunavir—Somnolence—Lisinopril—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Darunavir—Headache—Captopril—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Darunavir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Darunavir—Dyspepsia—Lisinopril—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Darunavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Darunavir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Darunavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Darunavir—Eosinophilia—Methotrexate—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Darunavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Darunavir—Fatigue—Lisinopril—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Darunavir—Shock—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Darunavir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Darunavir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Darunavir—Hypersensitivity—Leflunomide—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Darunavir—Pancreatitis—Methotrexate—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Darunavir—Constipation—Lisinopril—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Darunavir—Pain—Lisinopril—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Darunavir—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Darunavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Darunavir—Bradycardia—Prednisone—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Darunavir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Darunavir—Diarrhoea—Azathioprine—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Darunavir—Haemoglobin—Prednisone—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Darunavir—Nausea—Captopril—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Darunavir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Darunavir—Haemorrhage—Prednisone—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Darunavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Darunavir—Asthenia—Leflunomide—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Darunavir—Pancytopenia—Methotrexate—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Darunavir—Feeling abnormal—Lisinopril—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Darunavir—Pruritus—Leflunomide—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Darunavir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Darunavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Darunavir—Dysuria—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Darunavir—Neutropenia—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Darunavir—Dizziness—Azathioprine—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Darunavir—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Darunavir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Darunavir—Diarrhoea—Leflunomide—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Darunavir—Urticaria—Lisinopril—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Darunavir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Darunavir—Body temperature increased—Lisinopril—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Darunavir—Abdominal pain—Lisinopril—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Darunavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Darunavir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Darunavir—Vomiting—Azathioprine—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Darunavir—Eye disorder—Prednisone—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Darunavir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Darunavir—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Darunavir—Infestation NOS—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Darunavir—Infestation—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Darunavir—Rash—Azathioprine—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Darunavir—Dermatitis—Azathioprine—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Darunavir—Flushing—Prednisone—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Darunavir—Headache—Azathioprine—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Darunavir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Darunavir—Dizziness—Leflunomide—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Darunavir—Renal failure—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Darunavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Darunavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Darunavir—Stomatitis—Methotrexate—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Darunavir—Angiopathy—Prednisone—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Darunavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Darunavir—Immune system disorder—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Darunavir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Darunavir—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Darunavir—Haematuria—Methotrexate—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Darunavir—Vomiting—Leflunomide—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Darunavir—Alopecia—Prednisone—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Darunavir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Darunavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Darunavir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Darunavir—Epistaxis—Methotrexate—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Darunavir—Rash—Leflunomide—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Darunavir—Dermatitis—Leflunomide—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Darunavir—Mental disorder—Prednisone—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Darunavir—Nausea—Azathioprine—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Darunavir—Headache—Leflunomide—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Darunavir—Erythema—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Darunavir—Malnutrition—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Darunavir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Darunavir—Asthenia—Lisinopril—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Darunavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Darunavir—Pruritus—Lisinopril—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Darunavir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Darunavir—Haemoglobin—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Darunavir—Rash—Mycophenolic acid—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Darunavir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Darunavir—Haemorrhage—Methotrexate—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Darunavir—Hepatitis—Methotrexate—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Darunavir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Darunavir—Headache—Mycophenolic acid—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Darunavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Darunavir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Darunavir—Nausea—Leflunomide—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Darunavir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Darunavir—Urethral disorder—Methotrexate—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Darunavir—Diarrhoea—Lisinopril—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Darunavir—Ill-defined disorder—Prednisone—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Darunavir—Visual impairment—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Darunavir—Anaemia—Prednisone—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Darunavir—Agitation—Prednisone—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Darunavir—Angioedema—Prednisone—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Darunavir—Dizziness—Lisinopril—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Darunavir—Nausea—Mycophenolic acid—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Darunavir—Malaise—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Darunavir—Vertigo—Prednisone—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Darunavir—Syncope—Prednisone—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Darunavir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Darunavir—Loss of consciousness—Prednisone—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Darunavir—Vomiting—Lisinopril—systemic scleroderma	0.000363	0.000363	CcSEcCtD
Darunavir—Angiopathy—Methotrexate—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Darunavir—Rash—Lisinopril—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Darunavir—Convulsion—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Darunavir—Dermatitis—Lisinopril—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Darunavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Darunavir—Hypertension—Prednisone—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Darunavir—Chills—Methotrexate—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Darunavir—Headache—Lisinopril—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Darunavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Darunavir—Arthralgia—Prednisone—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Darunavir—Myalgia—Prednisone—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Darunavir—Anxiety—Prednisone—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Darunavir—Alopecia—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Darunavir—Discomfort—Prednisone—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Darunavir—Erythema—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Darunavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Darunavir—Nausea—Lisinopril—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Darunavir—Shock—Prednisone—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Darunavir—Nervous system disorder—Prednisone—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Darunavir—Tachycardia—Prednisone—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Darunavir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Darunavir—Skin disorder—Prednisone—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Darunavir—Hyperhidrosis—Prednisone—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Darunavir—Anorexia—Prednisone—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Darunavir—Anaemia—Methotrexate—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Darunavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Darunavir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Darunavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Darunavir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Darunavir—Malaise—Methotrexate—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Darunavir—Vertigo—Methotrexate—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Darunavir—Insomnia—Prednisone—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Darunavir—Paraesthesia—Prednisone—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Darunavir—Cough—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Darunavir—Convulsion—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Darunavir—Dyspepsia—Prednisone—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Darunavir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Darunavir—Chest pain—Methotrexate—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Darunavir—Myalgia—Methotrexate—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Darunavir—Decreased appetite—Prednisone—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Darunavir—Fatigue—Prednisone—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Darunavir—Discomfort—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Darunavir—Constipation—Prednisone—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Darunavir—Confusional state—Methotrexate—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Darunavir—Feeling abnormal—Prednisone—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Darunavir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Darunavir—Anorexia—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Darunavir—Urticaria—Prednisone—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Darunavir—Abdominal pain—Prednisone—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Darunavir—Body temperature increased—Prednisone—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Darunavir—Insomnia—Methotrexate—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Darunavir—Somnolence—Methotrexate—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Darunavir—Hypersensitivity—Prednisone—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Darunavir—Fatigue—Methotrexate—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Darunavir—Asthenia—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Darunavir—Pain—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Darunavir—Pruritus—Prednisone—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Darunavir—Diarrhoea—Prednisone—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Darunavir—Urticaria—Methotrexate—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Darunavir—Dizziness—Prednisone—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Darunavir—Vomiting—Prednisone—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Darunavir—Rash—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Darunavir—Dermatitis—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Darunavir—Headache—Prednisone—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Darunavir—Asthenia—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Darunavir—Nausea—Prednisone—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Darunavir—Pruritus—Methotrexate—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Darunavir—Dizziness—Methotrexate—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Darunavir—Vomiting—Methotrexate—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Darunavir—Rash—Methotrexate—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—systemic scleroderma	0.000179	0.000179	CcSEcCtD
Darunavir—Headache—Methotrexate—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Darunavir—Nausea—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
